CardioMech
PrivateLast Round
Convertible Debt
Jan 2, 2024
Total Funding Raised
$39M
Company Overview
CardioMech is a medical device company developing a transfemoral, transseptally delivered mitral valve chordal repair technology for patients with degenerative mitral regurgitation.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CardioMech Comparables
Compare CardioMech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CoreMedic | 94% | |
| Vesalius Cardiovascular | 93% | |
| Polares Medical | 89% | |
CardioMech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Convertible Debt | Jan 2, 2024 | ||||
| Series A | Aug 5, 2020 | ||||
| Convertible Debt | Aug 12, 2019 | ||||
| Convertible Debt | Feb 11, 2019 |
Key People
Founding team and executive leadership
CardioMech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Investinor | Convertible Debt, Series A |
| Hadean Ventures | Series A |
CardioMech Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about CardioMech's valuation, stock price, and market status.